A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling. Yet NARAL Pro-Choice America President Mini Timmaraju, who’s in close contact with the White House, tells “Conversations on Health Care” that’s not the right move. “I think calls for the FDA not to comply, while you know emotionally satisfying, are not actually helpful in a litigation strategy. And our goal is for the FDA and the DOJ to prevail in this case. The ruling…is riddled with serious disinformation.”
Timmaraju explains how the Supreme Court could hear the case by the end of this week and how this judge’s opinion could have an even bigger impact on the entire health care sector. Her interview with Mark Masselli and Margaret Flinter is online now.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast November 21, 2024 TV ads focused on health care issues — including transgender…
Originally broadcast November 14, 2024 There are 27 million Americans who have medical debt on…
Originally broadcast November 6, 2024The current life expectancy at birth is 74.8 years for males…
Originally broadcast April 9, 2024 The upcoming presidential election is stressing out 69% of American…
Originally broadcast October 17, 2024 For nearly the first decade of the National Institutes of…
Originally broadcast October 10, 2024 The countdown is on to election day with health care…